The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey

F Dorleans; C Giambi; L Dematte; S Cotter; P Stefanoff; J Mereckiene; D O’Flanagan; P L Lopalco; F D'Ancona; D Lévy-Bruhl; on behalf of the VENICE 2 project gatekeepers group

doi:10.2807/ese.15.47.19730-en

Rapid communications Open Access

Like 0

Download

The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey
F Dorleans¹ , C Giambi² , L Dematte³ , S Cotter⁴ , P Stefanoff⁵ , J Mereckiene⁴ , D O’Flanagan⁴ , P L Lopalco⁶ , F D'Ancona² , D Lévy-Bruhl¹ , on behalf of the VENICE 2 project gatekeepers group⁷
View Affiliations Hide Affiliations

Affiliations: ¹ Department of Infectious Diseases, Institut de Veille Sanitaire (InVS, French Institute for Public Health Surveillance), Paris, France ² National Centre for Epidemiology, Surveillance and Health Promotion, Istituto Superiore di Sanità (ISS, National Institute of Health), Rome, Italy ³ CINECA Consortium of Universities, Bologna, Italy ⁴ Health Protection Surveillance Centre (HPSC), Dublin, Ireland ⁵ National Institute of Public Heath- National Institute of Hygiene, Warsaw, Poland ⁶ Scientific Advice Unit, European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden ⁷ The members of the group are listed at the end of the article

Correspondence:
F Dorleans
f.dorleans invs.sante.fr
View Citation Hide Citation

Citation style for this article: Dorleans F, Giambi C, Dematte L, Cotter S, Stefanoff P, Mereckiene J, O’Flanagan D, Lopalco P L, D'Ancona F, Lévy-Bruhl D, on behalf of the VENICE 2 project gatekeepers group Collective. The current state of introduction of human papillomavirus vaccination into national immunisation schedules in Europe: first results of the VENICE2 2010 survey. Euro Surveill. 2010;15(47):pii=19730. https://doi.org/10.2807/ese.15.47.19730-en Received: 05 Nov 2010

Previous Article
Table of Contents
Next Article

Abstract

The Venice 2 human papillomavirus vaccination survey evaluates the state of introduction of the HPV vaccination into the national immunisation schedules in the 29 participating countries. As of July 2010, 18 countries have integrated this vaccination. The vaccination policy and achievements vary among those countries regarding target age groups, delivery infrastructures and vaccination coverage reached. Financial constraints remain the major obstacle for the 11 countries who have not yet introduced the vaccination.